InnoVita AI
BioTech/Drugs - Boston, MA, US
InnoVita AI Employees
Joseph Conroy
CEO - InnoVita AI - SARS-CoV Virus Detection & Elimination Technologies
InnoVita AI Senior Management
Joseph Conroy
CEO - InnoVita AI - SARS-CoV Virus Detection & Elimination Technologies
InnoVita AI Details
InnoVita develops technologies for for the following applications.♦SARS-CoV virus elimination (sterilization)♦Power Plants♦Power Grids♦Industrial Processes♦Waste Water Treatment FacilitiesOur most current and urgent focus is how to use our knowledge and technology to eliminate the SARS-COV-2 virus from interior spaces. Employing our own 20-years of artificial intelligence and sensor technologies, we have already designed a Covid-19 portable room sterilization unit called the "PRVS-4000". The PRVS-4000 design and performance is based on the best science and lab performance tests which the Centers For Disease Control (CDC) and the National Institute of Health (NIH) have produced.As of October 2020, the PRVS-4000's performance is 645% above the NIH laboratory tests which have resulted in a "deactivation" (i.e. elimination) of 99.99% of any SARS-Cov type virus. PRVS-4000 Design Features♦ 4 Pending Patents♦ Exceeds NIH lab test results by 645% on Coronaviruses♦ Using AI, the PRVS-4000 knows how many people are in the room♦ Using AI + IoT, the PRVS-4000 adjusts its performance according to room occupancy and the local infection rate (LIR) in order to achieve 99.99% virus deactivation on a single pass. ♦ (Future) the PRVS-4000 will be able to identify room participants who have a fever. Applications♦ Restaurants♦ Schools♦ Hospitals♦ Gyms♦ Any interior spacePRVS Product Types♦ Portable Room Sterilizer (PRVS-4000)♦ Table Top/Night Stand Sterilizer♦ Car/Mobile Sterilizer♦ Personal Inhalation Sterilizer
InnoVita AI Technologies
Domain Name Services
Cloudflare DNS
CMS
WordPress.org
Tag Management
Google Tag Manager
Hosting
CloudFlare Hosting
Analytics and Tracking
Google Analytics
Other
Mobile Friendly